Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 2 at 2:00 PM EDT

Register Free →
logo
Get CLEATUS

Radiation Oncology-Biology Integration Network (ROBIN) Centers (U54 Clinical Trial Required)

Active
Grant

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The contract aims to continue supporting the Radiation Oncology-Biology Integration Network (ROBIN), fostering a collaborative national research infrastructure focused on the biological changes in tumors and normal tissues during radiation therapy. This initiative targets both new and renewing investigators to engage in multidisciplinary, longitudinal studies that collect and analyze biospecimens and diverse data throughout the course of standard radiation treatments. The goal is to deepen the understanding of mechanisms behind treatment response, resistance, and toxicity, while identifying novel therapeutic targets and assessing the evolving effectiveness of treatment strategies as therapies progress. By integrating expertise across biology, clinical oncology, imaging, dosimetry, omics, biospecimen science, and data science, the network strengthens the radiation oncology workforce and accelerates translational research discoveries. These efforts are intended to inform future clinical trials and enhance radiation-based cancer care by uncovering how radiation alters molecular targets over time and identifying new opportunities to combine radiation with other therapies. Funded by the National Cancer Institute under the Department of Health and Human Services, the program requires clinical trials and emphasizes sustaining an agile, effective infrastructure to improve outcomes for cancer patients nationwide.

General Info

Support for ROBIN network enabling multidisciplinary radiation oncology research and improved cancer treatment outcomes.

Agency

Department Of Health And Human Services → National Institutes Of HealthView Agency

NAICS

541714 - Research and Development in Biotechnology (except Nanobiotechnology)View NAICS

Place of Performance

Not specified

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

Posted

forecast

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → National Institutes Of Health
Contacts1 person available
OfficeUSA
Organization / Agency
Department Of Health And Human Services → National Institutes Of Health
View Agency Profile
Office AddressUSA
Contacts
NCI ROBIN RFA
contact@example.gov

Full Description

Show more

Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) intends to continue to support the Radiation Oncology-Biology Integration Network (ROBIN) with applications from both new and renewing investigators. This network model will sustain an agile and effective national radiation oncology infrastructure that collectively addresses critical hypothesis-based translational research on the biological basis of responses in cancer patients who undergo radiation treatments. ROBIN supports a collaborative national research network focused on understanding how tumors and normal tissues change biologically during radiation therapy. Because radiation can dynamically alter molecular targets over the course of treatment, the network seeks to generate foundational knowledge that can improve radiation-based cancer care and identify new opportunities for combining radiation with drugs and other therapies. Through multidisciplinary, longitudinal studies, ROBIN centers collect and analyze biospecimens and multimodal data before, during, and after standard-of-care radiation therapy. This work is designed to reveal mechanisms of response, resistance, and toxicity; identify new therapy-induced targets; and determine whether treatment strategies based on initial tumor profiling remain optimal as therapy progresses. The network also strengthens the radiation oncology workforce by integrating expertise in biology, clinical oncology, imaging, dosimetry, omics, biospecimen science, and data science. By sustaining this research infrastructure, NIH aims to accelerate translational discoveries that can inform future clinical trials and improve outcomes for people with cancer.

Similar Contracts

Same NAICS industry code

NAICS: 541714
New
Federal
Trusted Partner Program Coming Soon - Update
Solicitation # W911NF26RA009
The Trusted Partner Program (TPP), under solicitation W911NF-26-R-A009, is a quick-reaction contracting vehicle designed to facilitate rapid Research, Development, Technology, and Evaluation (RDT&E) between the U.S. Army, Joint Warfighter partners, and external academic or non-profit research institutions. The program focuses on sensitive projects across core technical fields including biology, material science, electronics, chemistry, information sciences, and physics, as well as interdisciplinary areas such as applied AI, quantum battlefield dominance, and hypersonics. The government intends to award one or more Indefinite Delivery/Indefinite Quantity (ID/IQ) contracts with a base ordering period of five years and a potential five-year extension. Each awardee will have a total contract ceiling of 400 million dollars. The solicitation is currently on hold pending a review of Army priorities, which may lead to updates in the final Request for Proposals (RFP). Eligibility is restricted to institutes of higher education and non-profit research institutions, requiring CMMC Program Level 2 certification and the ability to handle various security classifications, ranging from Controlled Unclassified Information (CUI+) to Top Secret and Special Access Programs (SAP). Awards will be based on a best-value trade-off process, with technical capability being the most important factor, followed by management, past performance, small business participation, and cost. Proposals must include a specific technical expertise matrix and a video pitch demonstrating secure facilities. All invoicing and payments will be processed through the Wide Area WorkFlow (WAWF) system.
W6QK Acc-Apg Durham

POSTED

1 day ago

DEADLINE

N/A
View Details
NAICS: 541714
New
Federal
Q301--Strand-Specific RNA-Sequencing Services
Solicitation # 36C24126Q0788
The Department of Veterans Affairs, Network Contracting Office 1, is seeking a small business contractor to provide strand-specific RNA-sequencing services for 269 human choroid plexus total RNA samples. This firm-fixed-price contract involves sample quality-control assessment, rRNA depletion-based library preparation, and Illumina paired-end sequencing at 60 million read pairs per sample. The successful contractor must deliver FASTQ files and quality-control reports within 23 to 28 business days after receiving the samples as a single batch. The award will be granted to the responsible quoter with the lowest price that meets the technical requirements. Applicants must submit a technical capability statement demonstrating their experience with rRNA-depleted sequencing, their proposed methodology, and their ability to achieve a Phred quality score of Q30 or greater for at least 85 percent of bases. Questions are due by September 3, 2026, and final quotations must be submitted by September 10, 2026.
241-NETWORK Contract Office 01 (36C241)

POSTED

1 day ago

DEADLINE

in 9 days
View Details
NAICS: 541714
New
Federal
System Integration and Installation Support
Usuhs

POSTED

5 days ago

DEADLINE

in 7 days
View Details
NAICS: 541714
New
SBIR / STTR
Autonomous Navigation & Control Systems DevelopmentThe Defense Advanced Research Projects Agency under the U.S. Department of Defense is seeking a subcontract for the development of autonomous navigation and control systems. The project focuses on the design and simulation of navigation algorithms specifically for underwater vehicles operating in GPS-denied environments, utilizing a combination of acoustic, inertial, and environmental sensing technologies. This opportunity is designated as a Total Small Business Set-Aside under the SBIR/STTR mandate for companies with fewer than 500 employees, falling under NAICS code 541714. The solicitation was posted on August 26, 2026, with a response deadline of September 23, 2026.
Defense Advanced Research Projects Agency

POSTED

7 days ago

DEADLINE

in 22 days
View Details
NAICS: 541714
New
Federal
Preclinical Assessment of Naloxone Adequacy to Reverse Polysubstance Use-Induced Respiratory Depression — In Vivo Validation
Solicitation # 75F40126Q00382
The U.S. Food and Drug Administration is issuing a sole source, firm-fixed-price contract to Charles River Laboratories for a twelve month preclinical study. The research aims to evaluate the efficacy of naloxone and alternative reversal agents in treating respiratory depression caused by polysubstance use, specifically addressing the prevalence of fentanyl adulterated with xylazine, d-methamphetamine, or alprazolam. The study will utilize male CD rats to simultaneously measure respiratory and cardiovascular changes, as these systems are closely linked during drug-induced respiratory failure. The project consists of a four-phase in vivo study involving surgically instrumented animals. Key tasks include using whole body plethysmography for respiratory monitoring and implanted telemetry for continuous cardiovascular data collection. The contractor is responsible for collecting blood samples at five prespecified time points for pharmacokinetic analysis to be performed by the FDA. All work will be conducted in an AAALAC-accredited facility under non-GLP conditions, with statistical analysis performed via ANOVA.
FDA Office Of Acq Grant Svcs

POSTED

7 days ago

DEADLINE

in 9 days
View Details
NAICS: 541714
New
SBIR / STTR
Universal Cell Culture Platform for Rapid Establishment of Species-Agnostic Cell Lines and Autonomous Culture Operations
Solicitation # DPA26BZ05-DV020
Defense Advanced Research Projects Agency

POSTED

7 days ago

DEADLINE

in 22 days
View Details
NAICS: 541714
New
Grant
Clinical Research with Human SubjectsThe Department of Defense, through the Defense Health Agency Contracting Activity, is seeking a subcontractor for the design and execution of clinical research involving human subjects or human biospecimens. The scope of work encompasses critical research operations, including ensuring IRB compliance, managing participant recruitment, overseeing data management, and maintaining strict adherence to PHS inclusion standards. This opportunity is categorized under NAICS code 541714 and was posted on August 26, 2026. Interested parties must submit their responses by the deadline of November 4, 2026.
Defense Health Agency Contracting Activity - Dhaca

POSTED

7 days ago

DEADLINE

in 2 months
View Details
NAICS: 541714
New
SBIR / STTR
SBIR: UC-RAPID
Solicitation # DPA26BZ05-DV020
The SBIR UC-RAPID solicitation, issued by the Department of Defense Small Business Projects Office, seeks the development and demonstration of an automated, species-agnostic cell culture platform. This technology is intended to rapidly establish viable cell lines, including induced pluripotent stem cells, from a variety of non-model species to support the validation of genetic-biocontrol technologies. This opportunity is a total small business set-aside for companies with fewer than 500 employees. The solicitation was posted on August 26, 2026, with a response deadline of September 23, 2026.
Small Business Projects Office

POSTED

7 days ago

DEADLINE

in 21 days
View Details
NAICS: 541714
Federal
Firefox Proposers Day
Solicitation # DARPA-SN-26-112
The Firefox Program, managed by the Defense Advanced Research Projects Agency (DARPA) Biological Technologies Office (BTO), is a 36-month research and development initiative designed to prove and de-risk a technology pathway for a high-channel non-invasive brain-computer interface with single-neuron spatiotemporal resolution. The program is structured into three 12-month phases and is divided into two parallel technical areas: Technical Area 1, which focuses on the expansive scanning and rastering of a coherent optical beam, and Technical Area 2, which focuses on the development of analog data processing architectures. Under Special Notice DARPA-SN-26-112 and Amendment 01, DARPA is hosting an in-person Proposers Day on September 21, 2026, from 9:00 AM to 5:00 PM EDT at the SPA Arlington Research Collaboration Center in Arlington, Virginia. The event is intended to introduce the program vision, explain DARPA mechanics, and facilitate teaming through a poster session. Advance registration is required by September 11, 2026, with a limit of three attendees per organization. While attendance is optional and not required for future proposal submission, the event serves as a critical networking and information-gathering opportunity. All technical and administrative inquiries are directed to firefox@darpa.mil.
Defense Advanced Research Projects Agcy

POSTED

8 days ago

DEADLINE

in 10 days
View Details
NAICS: 541714
Federal
Local Technical Support and Installation ServicesThis subcontract involves the on-site installation, calibration, and integration of the Opentrons Flex system for the National Oceanic and Atmospheric Administration within the Department of Commerce. The scope of work includes comprehensive system validation and user training to ensure the equipment is fully operational at the federal research laboratory located in zip code 20746. The opportunity was posted on August 24, 2026, with a response deadline of September 8, 2026. Classified under NAICS code 541714, the project focuses on providing specialized local technical support and installation services to facilitate the successful deployment of the laboratory system.
National Oceanic And Atmospheric Administration

POSTED

9 days ago

DEADLINE

in 6 days
View Details
NAICS: 541714
SBIR / STTR
Export-Controlled Technology Development (ITAR/EAR Compliance)This subcontract opportunity with the U.S. Army under the Department of Defense focuses on research and development involving export-controlled technologies. The project requires strict adherence to ITAR and EAR regulations, specifically regarding the acquisition of necessary licenses and the proper disclosure of foreign nationals involved in the work. The opportunity is a total small business set-aside under NAICS code 541714, specifically mandated for SBIR/STTR participants with fewer than 500 employees. Interested parties must submit their responses by September 11, 2026, at 4:00 PM.
U.S. Army

POSTED

9 days ago

DEADLINE

in 10 days
View Details
NAICS: 541714
Federal
AN13--Intent to sole source - Miniaturized CO2 Sensor Prototype Development and Novel Physiologic Gas Monitoring Research
Solicitation # 36C24E26Q0110
The Department of Veterans Affairs RPO-E R&D intends to award a sole source Firm Fixed Price contract to the University of Michigan for the development of a miniaturized CO2 sensor prototype and research into novel physiologic gas monitoring. This notice serves as a public announcement of the intent to sole source under specific federal acquisition regulations and is not a request for proposals or quotations. Interested parties may submit capability information to demonstrate their ability to meet the requirements described in the statement of work by 10:00am EST on September 8, 2026. The government will review these submissions solely to determine if a competitive procurement is necessary. All inquiries and capability statements must be emailed to Contracting Officer Renee Kale, as telephone inquiries will not be accepted.
Rpo East (36C24E)

POSTED

9 days ago

DEADLINE

in 6 days
View Details

More opportunities from Department Of Health And Human Services → National Institutes Of Health

Same awarding agency

NAICS: 541715
Grant
Innovative Research to Improve Native Hawaiian and Pacific Islander (NHPI) Health Outcomes (R34 - Clinical Trial Optional)The National Institute on Minority Health and Health Disparities within the National Institutes of Health is issuing a forecast for planning grants titled Innovative Research to Improve Native Hawaiian and Pacific Islander (NHPI) Health Outcomes. These grants are designed to support preparatory, feasibility, and pilot activities that advance intervention development or solutions-oriented etiologic studies. A mandatory requirement for all projects is that they must be co-developed with community partners to ensure the effectiveness of the health outcomes being addressed. Priority areas for funding include formative studies on understudied contributors to chronic diseases like cancer and diabetes, as well as the adaptation and pilot-testing of interventions for maternal and infant health. Additionally, the program seeks feasibility and acceptability testing for strategies aimed at reducing behavioral risk factors, such as poor nutrition and smoking, to promote sustained behavior change and measurable improvements in health for NHPI populations.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

8 days ago

DEADLINE

N/A
View Details
NAICS: 334510
Grant
Small Instruments and Modern Equipment for Shared-use Biomedical Research Facilities and Resources (S15 Clinical Trial Not Allowed)The National Institutes of Health, under the Department of Health and Human Services, has issued a forecast for the Small Instruments and Modern Equipment for Shared-use Biomedical Research Facilities and Resources program. This funding opportunity is designed for eligible shared biomedical research facilities, such as core facilities, biorepositories, and model resource facilities, to acquire new small instruments or scientific equipment. The primary objective is to enhance the operational efficiency and capabilities of resources shared by multiple researchers. Priority is given to requests for small instruments utilizing emerging technologies or those that generate physical, chemical, or biomaterial outputs rather than standard digital data. It is important to note that funding is restricted and cannot be used for building-level infrastructure or highly specialized instruments that only indirectly support research. Clinical trials are not allowed under this specific opportunity.
Electromedical and Electrotherapeutic Apparatus Manufacturing

POSTED

9 days ago

DEADLINE

N/A
View Details
NAICS: 541715
Grant
Single Cell Opioid Responses in the Context of HIV (SCORCH) Program: Phase 2The National Institutes of Health, through the National Institute on Drug Abuse, is forecasting Phase 2 of the Single Cell Opioid Responses in the Context of HIV (SCORCH) program. This initiative builds upon Phase 1 research by utilizing single-nucleus datasets from human and animal postmortem brain tissue to investigate the interactions between Substance Use Disorder and HIV disease progression within the Central Nervous System. The program aims to employ advanced single cell approaches, including the study of RNA splicing, epigenomic features, and spatial interactions, to conduct both data mining and hypothesis-driven research. The ultimate goal is to enhance the mechanistic understanding of how these conditions affect the brain at subcellular and circuit levels to identify potential targets for novel therapeutic interventions.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

13 days ago

DEADLINE

N/A
View Details
NAICS: 541715
Grant
Translational Research in Maternal and Pediatric Pharmacology and TherapeuticsThe National Institutes of Health, through the Eunice Kennedy Shriver National Institute of Child Health and Human Development, intends to issue a Notice of Funding Opportunity for translational research in maternal and pediatric pharmacology and therapeutics. This initiative aims to improve safe and effective precision therapeutics for pregnant women, lactating women, infants, children, and adolescents. The program focuses on advancing precision medicine via novel tools and technologies, developing safer therapeutics, improving patient-provider communication regarding drug safety, and scaling evidence-based interventions. This forecast is part of the agency's stewardship of the Best Pharmaceuticals for Children Act and recommendations from the Task Force on Research Specific to Pregnant Women and Lactating Women. While the project outlines clear goals for enhancing medication effectiveness and safety across these specific patient populations, applications are not currently being solicited. Interested parties can coordinate with the Obstetric and Pediatric Pharmacology and Therapeutics Branch for further information.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

13 days ago

DEADLINE

N/A
View Details
NAICS: 541715
Grant
Senator Paul D. Wellstone Muscular Dystrophy Specialized Research Centers (MDSRC)The Senator Paul D. Wellstone Muscular Dystrophy Specialized Research Centers (MDSRC) is a legislatively mandated Centers of Excellence program managed by the National Institutes of Health under the Department of Health and Human Services. This initiative focuses on expanding and intensifying basic, translational, and clinical research regarding muscular dystrophy through interdisciplinary collaboration and shared resources. By supporting innovative center-based projects and providing robust training environments for emerging scientists, the program aims to achieve research outcomes that exceed the capabilities of stand-alone grants. A critical component of the program is its commitment to patient-centered research, actively engaging patient and advocacy communities to increase awareness and ensure that study designs are informed by patient perspectives. This forecast opportunity is supported by several grant authorities, including 42 U.S.C. 281, 283g, 285g, and 284h. Interested parties can coordinate with the NICHD Intellectual and Developmental Disabilities Branch for further information.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

13 days ago

DEADLINE

N/A
View Details
NAICS: 541715
Grant
Multimodal AI to Accelerate Precision Medicine for Type 1 Diabetes (U01- Clinical Trials Not Allowed)The National Institutes of Health, through the National Institute of Diabetes and Digestive and Kidney Diseases, is seeking a coordinated, milestone-driven research project titled Multimodal AI to Accelerate Precision Medicine for Type 1 Diabetes. This initiative aims to integrate large, longitudinal, and multimodal datasets from various T1D research consortia to examine how different biological processes, tissues, and organs interact to drive the development and progression of the disease. By combining human pancreas and clinical data, the project seeks to uncover new insights into T1D biology, identify biomarkers, and inform personalized approaches for prevention and treatment. To achieve these goals, the project will focus on the development and testing of advanced multimodal AI models and AI-enabled research workflows. Key technical objectives include creating new methods for data integration and generating privacy-preserving synthetic datasets. This effort is designed to move beyond the limitations of individual studies to provide a comprehensive understanding of the different forms and stages of Type 1 Diabetes, ultimately accelerating the advancement of precision medicine.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

13 days ago

DEADLINE

N/A
View Details
NAICS: 541714
Grant
Established Clinician Investigator Award to Support Mentoring (KS1)The Established Clinician Investigator Award to Support Mentoring (KS1) is a forecast opportunity issued by the National Institutes of Health under the Department of Health and Human Services. This award is designed to provide established clinician investigators with a sustained period of protected time, enabling them to deliver high-quality mentoring and guidance to early-career clinician research scientists. The program is managed by the Division of Biomedical Research Workforce, which serves as the primary point of contact for interested parties. While specific performance locations and set-aside details are not listed, the award aims to strengthen the pipeline of clinician researchers through structured mentorship support.
Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

20 days ago

DEADLINE

N/A
View Details
NAICS: 541715
Grant
Strategies to Innovate EmeRgENcy Care Clinical Trials Network (SIREN) Infrastructure – Clinical Coordinating Center (CCC) and Data Coordinating Center (DCC)The National Institutes of Health, through the National Institute of Neurological Disorders and Stroke and the National Heart, Lung and Blood Institute, is seeking to provide continued support for the Strategies to Innovate EmeRgENcy Care Clinical Trials Network (SIREN). This initiative focuses on conducting clinical trials to improve outcomes for patients experiencing non-stroke neurological and cardiovascular emergencies within pre-hospital or emergency department settings by identifying effective early-stage treatments. The program specifically seeks to establish a Clinical Coordinating Center (CCC) and a Data Coordinating Center (DCC) to support the network's infrastructure. While this notice serves as a forecast to allow potential applicants time to form collaborations and prepare responsive applications, formal solicitations are not currently being accepted.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

20 days ago

DEADLINE

N/A
View Details
NAICS: 611430
Grant
Mentored Career Transition Award (KT1/R00)The Mentored Career Transition Award (KT1/R00), issued by the National Institutes of Health under the Department of Health and Human Services, is a biphasic grant designed to transition postdoctoral researchers into independent, tenure-track faculty roles. The award provides up to five years of total support, beginning with a mentored career development phase lasting one to two years. The second phase offers up to three years of independent research funding, which is contingent upon the recipient's satisfactory progress during the initial phase and the procurement of an approved, research-intensive faculty position. This forecasted opportunity is managed by the Division of Biomedical Research Workforce.
Professional and Management Development Training

POSTED

20 days ago

DEADLINE

N/A
View Details
NAICS: 621910
Grant
Strategies to Innovate EmeRgENcy Care Clinical Trials Network (SIREN) Infrastructure – Clinical Enrollment HubsThe National Institutes of Health, through the National Institute of Neurological Disorders and Stroke and the National Heart, Lung and Blood Institute, is seeking to support the infrastructure for the Strategies to Innovate EmeRgENcy Care Clinical Trials Network (SIREN). This initiative focuses on establishing clinical enrollment hubs to conduct trials aimed at improving outcomes for individuals experiencing non-stroke neurological and cardiovascular emergencies within pre-hospital or emergency department settings. This notice serves as a forecast to allow potential applicants time to establish collaborations and develop responsive applications. While the program aims to identify effective early-stage treatments, applications are not currently being solicited. Interested parties can contact the NINDS Department of Emergency Medicine for further information.
Ambulance Services

POSTED

20 days ago

DEADLINE

N/A
View Details
NAICS: 541714
Grant
Alzheimer's Drug-Development Program (U01 Clinical Trial Optional)The National Institute on Aging is issuing a forecast for the Alzheimer's Drug-Development Program to support the pre-clinical and early-stage clinical Phase I development of novel biologic and small-molecule drug candidates. The program aims to identify treatments that prevent Alzheimer's disease, slow its progression, or address cognitive and behavioral symptoms. Funding is available for academic and biotech researchers to conduct development activities internally or through specialized contract research organizations. The initiative focuses on expanding the portfolio of investigational drug candidates for emerging therapeutic targets and diversifying the therapeutic pipeline to support mono-therapy, combination therapy, and precision medicine approaches. This opportunity will utilize the U01 activity code. While applications are not currently being accepted, this notice serves to allow potential applicants time to establish collaborations and design responsive projects.
Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

20 days ago

DEADLINE

N/A
View Details
NAICS: 541715
Grant
Mentored Research Scientist Career Development Award (KR1)The Mentored Research Scientist Career Development Award (KR1), issued by the National Institutes of Health under the Department of Health and Human Services, is designed to support candidates with research doctoral degrees in their pursuit of future research independence. The award provides up to five years of protected time for intensive career development under the guidance of an experienced mentor. This opportunity is currently listed as a forecast with a posted date of August 13, 2026. Interested parties can contact the Division of Biomedical Research Workforce via email at nihtrain@mail.nih.gov for further information.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

20 days ago

DEADLINE

N/A
View Details